Ayurvedic Management of Chronic Kidney Disease (Vrikka Vikara): A Case Study
DOI:
https://doi.org/10.48165/IRJAY.2026.90305Keywords:
Chronic Kidney Disease, Vṛikka Vikāra, Ayurvedic Management, Dietary Regimen, Lifestyle Modification, Renal Function, Metabolic Parameters. Attention RegulationAbstract
Chronic kidney disease (CKD) is a progressive disorder characterized by gradual loss of renal function, accumulation of metabolic waste products, and increased risk of cardiovascular and systemic complications. In Ayurveda, CKD can be correlated with Vrikka Vikara and disorders involving Mutravaha Srotodushti, where impairment of kidney function is associated with Tridosha imbalance, particularly Vata and Kapha, along with the accumulation of Ama (metabolic toxins) and vitiation of Rakta and Meda Dhatu. A 48-year-old male with a known case of chronic kidney disease (diagnosed in July 2022) presented to Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, on 07/05/2024, with multiple systemic manifestations. At the time of presentation, the patient exhibited generalized weakness (Daurbalya), fatigue (Shrama/Klama), foot pain (Pāda Śhūla), dyspnea on exertion (Shrama Janya Shwāsa), bilateral pedal edema (Ubhaya Pāda Śotha), mild facial puffiness (Mukha Śotha), frothy urine (Phenila Mutra), and nocturia (Naktamutratā). The patient was hospitalized for clinical monitoring and managed with Ayurvedic dietary and lifestyle interventions for ten days from 07/05/2024 to 17/05/2024. Laboratory parameters demonstrated significant improvement following the intervention. Blood urea decreased from 40.50 mg/dl to 17.50 mg/dl, serum creatinine from 1.91 mg/dl to 1.70 mg/dl, and uric acid from 8.74 mg/dl to 6.95 mg/dl. Lipid profile showed reduction in triglycerides (321.20 mg/dl to 201.47 mg/dl) and VLDL cholesterol (64.24 mg/dl to 40.29 mg/dl). Total bilirubin reduced from 1.82 mg/dl to 1.52 mg/dl, with stabilization of direct and indirect bilirubin levels, suggesting improved hepatic and metabolic homeostasis. DTPA renal scan revealed persistently compromised left kidney function (GFR 1.4–1.9 ml/min) and compensatory improvement in the right kidney (GFR 27.9–32.8 ml/min), with global GFR increasing from 29.4 ml/min to 34.7 ml/ min. This case demonstrates that comprehensive Ayurvedic management, incorporating dietary regulation, lifestyle modification, and patient-centered care, can lead to significant clinical and biochemical improvement in patients with chronic kidney disease, even in the presence of longstanding comorbidities such as hypertension. While the structural damage in the left kidney remained irreversible, the compensatory improvement in right renal function, along with enhanced metabolic and lipid parameters, underscores the potential of integrative approaches in supporting renal function and overall systemic health.
Downloads
References
Sangamesh M, Hegde R, Dsouza V. A case study on the management of alcohol dependence through Ayurveda. J Ayurveda Integr Med Sci. 2024;9(5):284-290.
Bhagiya SG, Trivedi DD, Baravaliya R. Exploring Panchakarma therapy in the management of Wilson disease: An observation. J Ayurveda Case Rep. 2024;7(1):54-59.
Pokhriyal AC, Juyal D, Mukhopadhyay S. A review on Panchakarma: Comprehensive approach in neurological disorders. Biochem Cell Arch. 2024;24(1).
Adiga SH, Adiga RS, Bhat KM, Upadhya D. Ayurveda therapy in the management of epilepsy. Epilepsy Behav. 2024;159:110026.
Chakma P, Kumar K. Efficacy of Ayurvedic treatments in stress management. J Ayurveda Integr Med Sci. 2024;9(9):234-240.
Purushothaman V, Santhanam R, Ravi P, Kuppusamy M. Development and validation of yoga program for patients with chronic kidney disease. Indian J Palliat Care. 2024;30(4):380.
Aggarwal A, Sokiya G, Sharma G. Management of chronic kidney disease—An Ayurveda case study. J Ayurveda Integr Med Sci. 2023;8(7):250-256.
Tsai HJ, Wu PY, Huang JC, Chen SC. Environmental pollution and chronic kidney disease. Int J Med Sci. 2021;18(5):1121.
Hustrini NM, Susalit E, Rotmans JI. Prevalence and risk factors for chronic kidney disease in Indonesia: An analysis of the National Basic Health Survey 2018. J Glob Health. 2022;12.
Kovesdy CP. Epidemiology of chronic kidney disease: An update 2022. Kidney Int Suppl. 2022;12(1):7-11.
Acharya M, Chaudhary G, Singh SP, Singh M, Richa. Clinical evaluation of chronic kidney disease management: Integrating lifestyle modification and Ayurveda. Int J AYUSH. 2024;13(10):1152. doi:10.22159/prl.ijayush.v13i10.1152.
Charaka. Charaka Samhita. Vols I-VI. Jamnagar: Shree Gulab Kunverba Ayurvedic Society; 1949.
Beauty K, Talib S, Mohd E. Phytochemistry and pharmacology of Helicteres isora Linn. (Marodphali): Ayurvedic insights and medicinal overview. Int J Ayurveda Pharma Res. 2024:118-128.
Das SK, Mohanty B. The smelliest spice in the world Asafoetida (Ferula narthex Boiss.): Health benefits. In: Medicinal Spices and Herbs from India. Apple Academic Press; 2024. p. 253-278.
Pawar SH, Patil AB, Deshpande M, Patil T, Jawale S. Review of Jatwadi Dhoom Agad as a proposed fumigation product for mosquito repellent and antimicrobial action. Int J Res Pharm Sci. 2021;12(4):2460-2468.
Vartak A, Sonawane S, Alim H, Patel N, Hamrouni L, Khan J, Ali A. Medicinal and aromatic plants in the cosmetics industry. In: Medicinal and Aromatic Plants of India. Vol. 1. Cham: Springer International Publishing; 2022. p. 341-364.
Tyagi T, Sharma S, Sharma R. Pharmacological actions of Valeriana wallichii (Tagara): A fundamental analysis supporting traditional benefits. Int J Ayurveda Pharma Res. 2022;10:1-7.
Manish Ji A, Chaudhary G, Richa, Singh SP, Singh M. A case report on the integrative management of chronic kidney disease: An Ayurvedic approach. Acad J Med. 2024;7(2):Article 20705. doi:10.48165/ajm.2024.7.02.9.
Acharya M. Clinical evaluation of chronic kidney disease management: Integrating lifestyle modification and Ayurveda. Int J AYUSH. 2024;13(10). doi:10.22159/prl.ijayush.v13i10.1152.
Singh AP, Grover M, Gautam A. Effective management of chronic kidney disease by using Ayurvedic interventions: A case report. Int J Ayurveda Pharma Res. 2021;9(7):26-30. doi:10.47070/ijapr.v9i7.1979.
V R D, P M M. Chronic kidney disease—Ayurvedic perspective. Kerala J Ayurveda. Published online 2025. doi:10.55718/kja.284.
Charaka. Charaka Samhita. Vols I-VI. Jamnagar: Shree Gulab Kunverba Ayurvedic Society; 1949.
Kolhe R, Acharya R. Analyzing the drug safety issue in Bhavaprakasha Nighantu: A critical review. Ayurpharm Int J Ayurveda Allied Sci. 2015;4:183-196.
Singh PA, Dash S, Choudhury A, Bajwa N. Factors affecting long-term availability of medicinal plants in India. J Crop Sci Biotechnol. 2024;27(2):145-173.
Gajera MD, Nayak NR, Kande A. Hypertension in light of Ayurveda: A review article. J Ayurveda Integr Med Sci. 2024;9(5):59-71.
Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an Ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186.
Vishwakarma R, Goswami PK. A review through Charaka Uttara-Tantra. AYU. 2013;34(1):17-20.
Bhide VP, Misra VN, editors. Sushruta Samhita. Reprint ed. Varanasi: Chaukhambha Orientalia; 2006. Sutra Sthana, Chapter 12, Verse 11.
Bhalodia SG, Bhuyan C, Gupta SK, Dudhamal TS. Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of benign prostatic hyperplasia. AYU. 2012;33(4):547-551.
Sheoran P, Panda JK, Tanwar S. Ayurvedic synergy: Combining principles for optimal PCOD management—A case study. J Ayurveda Integr Med Sci. 2025;10(5):324-330.

